Exchange: STO Sector: Healthcare Industry: Biotechnology
-0.48% SEK1.035
America/New_York / 17 mai 2024 @ 11:07
FUNDAMENTALS | |
---|---|
MarketCap: | 21.97 mill |
EPS: | 12.89 |
P/E: | 0.0800 |
Earnings Date: | Jun 27, 2024 |
SharesOutstanding: | 21.23 mill |
Avg Daily Volume: | 0.0295 mill |
RATING 2024-05-17 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Neutral | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | ||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0.0800 | sector: PE 19.76 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE 0.0800 | industry: PE 491.84 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
SEK 0.764 - 1.296 ( +/- 25.83%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | SEK1.035 (-0.48% ) |
Volume | 0.0073 mill |
Avg. Vol. | 0.0295 mill |
% of Avg. Vol | 24.60 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.